Avoiding recurrence of infection and minimising autoimmunity-induced side effects
29 Oct 2024
Immune Regulation
- Risks of side effects caused by dysregulated immune system in drug development
- Potential risks of immune senescence and aging in patients
- Risks and management of autoimmune diseases after immune checkpoint blockade (ICB) therapy
- Risks and management of infection after CAR-T therapy for B cell malignancy
Industry Experts
